Abstract
Aging is characterized by an increased susceptibility to infectious diseases; influenza virus infection, which is easily managed by an intact immune system, represents a life-threatening disease in aged subjects. We studied 18 healthy aged subjects (>65 years of age), vaccinated yearly with conventional anti-influenza vaccine, and 9 healthy young volunteers (mean age 26 years), without previous anti-influenza vaccination, who were vaccinated with the conventional trivalent 1990 anti-influenza preparation. Six out of the 18 aged individuals received a second boost of the same vaccine about 4 months later. In all subjects, we analyzed the humoral response to type A and B influenza viruses and the influenza type A virus-specific CTL generation. Among the elderly population with a single vaccination, 6 and 5 subjects seroconverted against type A and type B influenza virus respectively. Young subjects seroconverted in 5 cases against type A, and in 5 cases against type B influenza virus. Seroconversion took place after the second vaccination in only one subject, and the antibody production was type A specific. Influenza type A virus-specific CTL activity was significantly lower in aged subjects, compared with the values observed in the young volunteers (p=0.017). The second vaccination partially restored this immunological impairment. These data clearly demonstrate that the elderly do not have the same ability as younger subjects to mount an antibody response, and generate influenza type A virus-specific CTL after conventional anti-influenza vaccination. Moreover, a double anti-influenza vaccination generates CTL activity levels comparable to young subjects, although it does not seem to substantially modify the antibody production. (Aging Clin. Exp. Res. 5: 451–458, 1993)
Similar content being viewed by others
References
Weksler M.E.: Senescence of the immune system. Med. Clin. North Am. 67: 263–272, 1983.
Thoman M.L., Weigle W.O.: The cellular and subcellular bases of immunosenescence. Adv. Immunol. 46: 221–261, 1989.
Effros R.B., Walford R.L.: The immune response of aged mice to influenza: diminished T-cell proliferation, interleukin-2 production and cytotoxicity. Cell. Immunol. 81: 298–305, 1983.
Effros R.B., Walford R.L.: The effect of age on the antigen-presenting mechanism in limiting dilution precursor cell frequency analysis. Cell. Immunol. 88: 531–539, 1984.
Cossarizza A., Ortolani C., Paganelli R., Monti D., Barbiera D., Sansoni P., Fagiolo U., Forti E., Londei M., Franceschi C.: Age related imbalance of virgin (CD45RA+) and memory (CD45RO+) cells between CD4 and CD8 T lymphocytes in humans: a study from newborns to centenarians. J. Immunol. Res. 4: 118–126, 1992.
Thoman M.L., Weigle W.O.: Lymphokines and aging: interleukin-2 production and activity in aged animals. J. Immunol. 127: 2102–2106, 1981.
Frasca D., Adorini L., Mancini C., Doria G.: Reconstitution of T-cell function in aging mice by thymosin alpha one. Immunopharmacology 11: 155–163, 1986.
Amadori A., Zanovello P., Cozzi E., Ciminale V., Borghesan F., Fagiolo U., Crepaldi G.: Study of some early immunological parameters in aging humans. Gerontology 34: 277–283, 1988.
Barcellini W., Borghi M.O., Sguotti C., Palmieri R., Frasca D., Meroni P.L., Doria G., Zanussi C.: Heterogeneity of immune responsiveness in healthy elderly subjects. Clin. Immunol. Immunopathol. 47: 142–151, 1988.
Rabinowich H., Goses Y., Reshef T., Klajman A.: Interleukin-2 production and activity in aged humans. Mech. Ageing Dev. 32: 213–226, 1985.
Smith I.M.: Infectious disease in the elderly patients. Geriatrics 35: 51, 1980.
Becq-Giraudon B., Breux J.Ph.: Les particularités de l’infection chez le sujet âgé. Presse Med. 19: 1259–1260, 1990.
Strassburg M.A., Greenland S., Sorvillo F.J., Lieb L.E., Mabel L.A.: Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine 4: 38–44, 1986.
Glezen W.P.: Serious morbidity and mortality associated with influenza epidemics. Epidemiol. Rev. 4: 25–44, 1982.
Leads from the MMWR: Prevention and control of influenza. JAMA 256: 323–329, 1986.
Saah A.J., Neufeld R., Rodstein M., La Montagne J.R., Blackwelder W.C., Gross P., Quinann G., Kaslow R.A.: Influenza vaccine and pneumonia mortality in a nursing home population. Arch. Intern. Med. 146: 2353–2357, 1986.
Nicholson K.G.: Influenza vaccination and the elderly. Br. Med. J. 301: 617–618, 1990.
Zharhary D., Klinman N.R.: Antigen responsiveness of the mature and generative B-cell population of aged mice. J. Exp. Med. 157: 1300–1304, 1983.
Ershler W.B., Moore A.L., Socinski M.A.: Influenza and aging: age-related changes and the effects of thymosin on the antibody response to influenza vaccine. J. Clin. Immunol. 4: 445–454, 1984.
McMichael A.J., Gotch F.M., Noble G.R., Beare P.A.S.: Cytotoxic T-cell immunity to influenza. N. Engl. J. Med. 309: 13–17, 1983.
Gotch F., McMichael A., Smith G., Moss B.: Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes. J. Exp. Med. 165: 408–416, 1987.
Kuwano K., Scott M., Young J.F., Ennis F.A: Active immunization against virus infections due to antigen drift by induction of crossreactive cytotoxic T lymphocytes. J. Exp. Med. 169: 1361–1371, 1989.
Biasi G., Facchinetti A., Panozzo M., Zanovello P., Chieco-Bianchi L., Collavo D.: Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice. J. Immunol. 147: 2284–2289, 1991.
Lighthart G.L., Courberaud J.X., Foumier G., Galanaud P., Hijmans W., Kennes B., Muller-Hermelink H.K., Steinmann G.G.: Admission criteria for immunogerontological studies in man: the Senieur protocol. Mech. Ageing Dev. 28: 47–55, 1984.
Barret T., Inglis S.C.: Growth, purification and titration of influenza viruses. In: Many B.W.J. (Ed.), Virology a practical approach. Irl Press, Oxford, Washington DC, 1985, pp. 119–150.
Harmon M.W.: Influenza viruses. In: Lennette E.H. (Ed.), Laboratory diagnosis of viral infections, ed. 2. M. Dekker Inc., 1992, pp. 515-534.
Amadori A., De Rossi A., Faulkner-Valle G.P., Chieco-Bianchi L.: Spontaneous in vitro production of virus-specific antibody by lymphocytes from HIV-infected subjects. Clin. Immunol. Immunopathol. 46: 342–351, 1988.
McMichael A.J., Michie C.A., Gotch F.M., Smith G.L., Moss B.: Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. J. Gen. Vir. 67: 719–726, 1986.
Recommendations of the Immunization Practices Advisory Committee, Prevention and Control of Influenza. MMWR 36: 373–375, 1987.
Oldstone B.A.: Molecular anatomy of viral persistance. J. Virol. 65: 6381–6386, 1991.
Callard R.E., Basten A.: Immune function in aged mice. IV. Loss of T-cell and B-cell function in thymus-dependent antibody responses. Eur. J. Immunol. 8: 552–558, 1978.
Kishimoto S., Tomino S., Mitsuya H., Fujiwara H., Tsuda H.: Age-related decline in the in vitro and in vivo synthesis of anti-tetanus antibody in humans. J. Immunol. 125: 2345–2352, 1980.
Rouse B.T., Norley S., Martin S.: Antiviral cytotoxic T lymphocyte induction and vaccination. Rev. Infect. Dis. 10: 16–33, 1988.
Taylor P.M., Askonas B.A.: Influenza nucleoprotein specific T cell clones are protective in vivo. Immunology 54: 417–419, 1986.
Effros R.B., Walford R.L.: Diminished T-cell response to influenza virus in aged mice. Immunology 49: 387–392, 1983.
Braciale T.J., Morrison L.A., Sweetser M.T., Sambrook T., Gething M.J., Braciale V.L.: Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes. Immunol. Rev. 98: 95–114, 1987.
Morrison L.A., Lukacher A.E., Braciale V.L., Fan D., Braciale T.J.: Differences in antigen presentation to MHC class I and class II-restricted influenza virus-specific cytolytic T lymphocyte clones. J. Exp. Med. 163: 903–921, 1986.
Ennis F.A., Rook A.H., Qi Y.U., Schild G.C., Riley D., Pratt R., Potter C.W.: HLA restricted virus-specific cytotoxic T-lymphocyte response to live and inactivated influenza vaccines. Lancet II: 887–891, 1981.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fagiolo, U., Amadori, A., Cozzi, E. et al. Humoral and cellular immune response to influenza virus vaccination in aged humans. Aging Clin Exp Res 5, 451–458 (1993). https://doi.org/10.1007/BF03324202
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03324202